Sir Colin Terence Dollery (14 March 1931 – 12 December 2020) was a clinical pharmacologist who spent much of his life working for SmithKline Beecham and its successor,
Glaxo Smith Kline
GSK plc, formerly GlaxoSmithKline plc, is a British Multinational corporation, multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a Mergers and acquisitions, merger of Gl ...
. He was knighted in the Queen's 1987 birthday honours. He was an honorary fellow of the
British Pharmacological Society
The British Pharmacological Society is the primary UK learned society for pharmacologists concerned with research into drugs and the way they work. Members work in academia, industry, regulatory agencies and the health services, and many are medi ...
and a fellow of the Academy of Medical Sciences.
After graduating in medicine from the
University of Birmingham
, mottoeng = Through efforts to heights
, established = 1825 – Birmingham School of Medicine and Surgery1836 – Birmingham Royal School of Medicine and Surgery1843 – Queen's College1875 – Mason Science College1898 – Mason Univers ...
in 1956, Dollery specialized in clinical pharmacology. He was appointed as a lecturer in therapeutics at the Royal Postgraduate Medical School, London, in 1963, being promoted to Professor of Clinical Pharmacology in 1968.
During his career he was:
*Founding Chairman of the Clinical Pharmacology Section of the British Pharmacological Society (1975–1975)
*Chair of the Clinical Section of the
International Union of Pharmacology (IUPHAR; 1975–1978)
*President of the IUPHAR (1987–1990).
He received many awards including the Wellcome Gold Medal awarded by the
British Pharmacological Society
The British Pharmacological Society is the primary UK learned society for pharmacologists concerned with research into drugs and the way they work. Members work in academia, industry, regulatory agencies and the health services, and many are medi ...
. His work led to major advances in cardiovascular pharmacology including work with the Nobel Laureate, Sir
James Black concerning
beta blocker
Beta blockers, also spelled β-blockers, are a class of medications that are predominantly used to manage cardiac arrhythmia, abnormal heart rhythms, and to protect the heart from a second myocardial infarction, heart attack after a first heart ...
s. Dollery spent time in both academia and industry (SmithKline Beecham and then GSK post the merger). He was also active within IUPHAR, where he was part of the clinical translational pharmacology group of the Nomenclature Committee.
His fields of interest included hypertension and drug safety.
In 1993 he gave the
Harveian Oration
The Harveian Oration is a yearly lecture held at the Royal College of Physicians of London. It was instituted in 1656 by William Harvey, discoverer of the systemic circulation. Harvey made financial provision for the college to hold an annual feas ...
.
Books
Books authored or edited include:
*
*
*
References
Further reading
*, a video biography compiled by the British Pharmacological Society
*
*
External links
Linkedin profile
{{DEFAULTSORT:Dollery, Colin
Alumni of the University of Birmingham
Academics of Imperial College London
Clinical pharmacologists
Fellows of the Academy of Medical Sciences (United Kingdom)
Fellows of the British Pharmacological Society
People educated at Lincoln Grammar School